Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Bullboard Posts
Post by TheCypheron Oct 16, 2018 9:01pm
265 Views
Post# 28814848

NOTES FROM THE PREV MEETING IN MONTREAL 📝👀

NOTES FROM THE PREV MEETING IN MONTREAL 📝👀
Notes from today’s presentation: 

PREV buying Penta5 for revenue to support R&D. This year's sales $149m. Next year $400m.

They sell a mosquito pack and taking to Walmart, Saudi Arabia, Jamaica etc

That's in addition to 125 patents and 72 products ready to go to market

They expect to close the penta 5 purchase by mid November

He (Stephen Deventer) kept mentioning Aurora in the "we" tense

Aurora has a large database on patients that they are sharing with PREV

price on Aurora’s 12 million options is 13.5 cents

With performance incentives (?)

Someone was filming the first 15 minutes for the PREV investors FB group.

Asterion will get all licenses in australia within 90 days and will break ground in January

With more square footage than Aurora

He mentioned something else... Penta has 1 of 99 liquor licenses in the US. License to make liquor

Their plan is to either sell or license it out for additional revenue and possible dividend to shareholder


 In addition asterion and Stephen are taking the lead in Australia. He was invited to be on the government board to influence regulations there

He plans to have a fully automated greenhouse and has mechanisms in place to make it the lowest cost production in the world.
He said No chance of losing any crops

His personal holy grail is the dual gene therapy for diabetes

The warrants at 13.5 cents can be purchased only if they get a sales contract with Jamaica and Costco And the department of defence

He's a smart business man

They are also looking at curing macular degeneration

He is aiming to outdo Aurora, Bigger square footage of greenhouse and lower production costs.

They are aiming to silence the gene that influences both obesity and diabetes

Government and Health care are already showing interest in their dual gene therapy

 
 
Bullboard Posts